G V Guibas1,2,3, M Tsolia4, I Christodoulou4, F Stripeli4, Z Sakkou4, N G Papadopoulos1,2,3,4. 1. Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK. 2. Allergy Department, Manchester University NHS Foundation Trust, Manchester, UK. 3. Paediatric Allergy Department, Manchester University NHS Foundation Trust, Manchester, UK. 4. 2nd Paediatric Clinic, University of Athens, Athens, Greece.
Abstract
BACKGROUND: Rhinovirus (RV) is an established trigger of asthma attacks, whereas such a link is less consistent for influenza virus (IFV). OBJECTIVE: In the context of precision medicine, we hypothesized that IFV infection may cause a condition essentially different from RV, and we investigated this by evaluating clinical characteristics of RV/IFV-positive and -negative children with respiratory symptoms and/or fever. METHODS: One thousand two hundred and seven children, 6 months to 13 years old, hospitalized for flu-like illness were recruited in this cross-sectional study. Collected information included demographics, medical history, symptoms/physical findings/diagnosis at presentation and treatment. Nasal secretions were PCR-tested for IFV/RV. Associations were evaluated with adjusted logistic regression models. RESULTS: Rhinovirus positivity was associated with an asthma-like presentation, including increased wheeze/effort of breathing/diagnosis of acute asthma, and decreased fever/vomiting. Conversely, IFV+ children presented with less wheeze/effort of breathing/diagnosis of acute asthma, while they were more frequently febrile. In those with previous asthma history, both viruses induced wheeze; however, IFV was uniquely associated with a more generalised and severe presentation including fever, rales, intercostal muscle retractions and lymphadenopathy. These symptoms were not seen in RV+ asthmatics, who had fewer systemic signs and more cough. CONCLUSIONS AND CLINICAL RELEVANCE: In children with respiratory symptoms and/or fever, RV but not IFV is associated with wheeze and an asthma-like presentation. In those with an asthma history, IFV causes more generalised and severe disease that may be better described as "asthma-augmented influenza" rather than an "asthma attack." Differences in the acute conditions caused by these viruses should be considered in the design of epidemiological studies.
BACKGROUND: Rhinovirus (RV) is an established trigger of asthma attacks, whereas such a link is less consistent for influenza virus (IFV). OBJECTIVE: In the context of precision medicine, we hypothesized that IFVinfection may cause a condition essentially different from RV, and we investigated this by evaluating clinical characteristics of RV/IFV-positive and -negative children with respiratory symptoms and/or fever. METHODS: One thousand two hundred and seven children, 6 months to 13 years old, hospitalized for flu-like illness were recruited in this cross-sectional study. Collected information included demographics, medical history, symptoms/physical findings/diagnosis at presentation and treatment. Nasal secretions were PCR-tested for IFV/RV. Associations were evaluated with adjusted logistic regression models. RESULTS: Rhinovirus positivity was associated with an asthma-like presentation, including increased wheeze/effort of breathing/diagnosis of acute asthma, and decreased fever/vomiting. Conversely, IFV+ children presented with less wheeze/effort of breathing/diagnosis of acute asthma, while they were more frequently febrile. In those with previous asthma history, both viruses induced wheeze; however, IFV was uniquely associated with a more generalised and severe presentation including fever, rales, intercostal muscle retractions and lymphadenopathy. These symptoms were not seen in RV+ asthmatics, who had fewer systemic signs and more cough. CONCLUSIONS AND CLINICAL RELEVANCE: In children with respiratory symptoms and/or fever, RV but not IFV is associated with wheeze and an asthma-like presentation. In those with an asthma history, IFV causes more generalised and severe disease that may be better described as "asthma-augmented influenza" rather than an "asthma attack." Differences in the acute conditions caused by these viruses should be considered in the design of epidemiological studies.
Authors: Nikolaos G Papadopoulos; Adnan Custovic; Antoine Deschildre; Alexander G Mathioudakis; Wanda Phipatanakul; Gary Wong; Paraskevi Xepapadaki; Ioana Agache; Leonard Bacharier; Matteo Bonini; Jose A Castro-Rodriguez; Zhimin Chen; Timothy Craig; Francine M Ducharme; Zeinab Awad El-Sayed; Wojciech Feleszko; Alessandro Fiocchi; Luis Garcia-Marcos; James E Gern; Anne Goh; René Maximiliano Gómez; Eckard H Hamelmann; Gunilla Hedlin; Elham M Hossny; Tuomas Jartti; Omer Kalayci; Alan Kaplan; Jon Konradsen; Piotr Kuna; Susanne Lau; Peter Le Souef; Robert F Lemanske; Mika J Mäkelä; Mário Morais-Almeida; Clare Murray; Karthik Nagaraju; Leyla Namazova-Baranova; Antonio Nieto Garcia; Osman M Yusuf; Paulo M C Pitrez; Petr Pohunek; Cesar Fireth Pozo Beltrán; Graham C Roberts; Arunas Valiulis; Heather J Zar Journal: J Allergy Clin Immunol Pract Date: 2020-06-17
Authors: Kai Sen Tan; Anand Kumar Andiappan; Bernett Lee; Yan Yan; Jing Liu; See Aik Tang; Josephine Lum; Ting Ting He; Yew Kwang Ong; Mark Thong; Hui Fang Lim; Hyung Won Choi; Olaf Rotzschke; Vincent T Chow; De Yun Wang Journal: Cells Date: 2019-08-27 Impact factor: 6.600
Authors: Kai Sen Tan; Rachel Liyu Lim; Jing Liu; Hsiao Hui Ong; Vivian Jiayi Tan; Hui Fang Lim; Kian Fan Chung; Ian M Adcock; Vincent T Chow; De Yun Wang Journal: Front Cell Dev Biol Date: 2020-02-25
Authors: Tuomas Jartti; Unna Liimatainen; Paraskevi Xepapadaki; Tero Vahlberg; Claus Bachert; Susetta Finotto; Marek L Kowalski; Anna Sobanska; Heikki Lukkarinen; Maria Pasioti; Tytti Vuorinen; Nan Zhang; Theodor Zimmermann; Nikolaos G Papadopoulos Journal: Allergy Date: 2020-07-21 Impact factor: 13.146